A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Financial Summary
| Share Statistics | GLAPY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,280.3 | $1,645.5 | 71% |
|
| Shares Out (Mil) | 248.4 | 72.9 | 80% |
|
| Institutional Ownership | 49.2% | 50.0% | 23% |
|
| Float (Mil) | 205.2 | 77.1 | 74% |
|
| Beta | 0.53 | 0.39 | 30% |
|
| Avg Daily Volume (000s) | 1 | 62 | 4% |
|
| Price Change (52-week) |
57.3% | 75.9% | 83% |
|
| Growth | GLAPY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (3.3%) | 6.5% | 11% |
|
| Net Income (5yr) | 0.9% | 1.7% | 41% |
|
| EPS (5yr) | 4.0% | 2.6% | 36 |
|
| Dividends (5yr) | 9.1% | 0.0% | 69% |
|
| Cash Flow (5yr) | 14.9% | (15.2%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | GLAPY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,946 | $2,139 | 71% |
|
| Net Income (TTM) (Mil) | $183 | $96 | 67% |
|
| EPS (TTM) | $0.732 | $0.300 | 57% |
|
| Operating Cash Flow (TTM) (Mil) | $369 | $240 | 67% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $4 | 41% |
|
| Long-Term Debt (Q1) (Mil) | $730 | $497 | 63% |
|
| Enterprise Value (Q1) (Mil) | $6,181 | $3,079 | 66% |
|
| Valuation | GLAPY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.71 | na |
|
| P/E | na | 16.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | GLAPY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 26.9% | 29.1% | 31% |
|
| Net Margin | 4.6% | 3.8% | 47% |
|
| ROA | 4.7% | 3.0% | 71% |
|
| ROE | 9.2% | 8.8% | 55% |
|
| Liabilities to Assets | 51.5% | 52.7% | 44% |
|
| F-Score | na | 4 | na |
|
Glanbia plc did not pass any screens on 7/31/2026.
